Investigation the effect of the " Prunus Dulcis Linctus" on treatment of cough

Investigation the effect of the " Prunus Dulcis Linctus" on asthmatic Patients ( refractory with chronic cough)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210315050707N1

Enrollment

100

Registered

2021-06-01

Start date

2021-04-21

Completion date

Unknown

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma. Asthma

Interventions

Intervention 1: Intervention group: the intervention group including fifty people, whose admission requirements has been confirmed according to determined criteria, was treated with 15 g of the Prunus

Eligibility

Sex/Gender

All

Age

14 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with asthma whose cough has not been treated with common medications. Patients over 14 years Patients who have signed the consent form.

Exclusion criteria

Exclusion criteria: Patients with Kidney failure and Diabetes Patients who were unavailable for follow-up

Design outcomes

Primary

Measure	Time frame
Refractory Asthma. Timepoint: Comparison of Spirometry values as well as patient history before and two weeks after the "Prunus Dulcis Linctus" consumption. Method of measurement: Spirometry test - Cough Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Seyyedi

Tabriz University of Medical Sciences

maryamsiedy@yahoo.com+98 41 3361 9279

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026